Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
The current price of Abbott Laboratories in the market is 907,11 kr, with a 24-hour trading volume of 5,81B kr. The asset's market cap is 1,57T kr, after moving -1.27% in the last day.
Tokenized Abbott Laboratories is trading at 917,21 kr, with a tokenized market cap of 305,45M kr and a 24-hour trading volume of 14,21M kr. The tokenized asset has moved 1.21% in the past 24 hours.